Preview

Systemic Hypertension

Advanced search

Parameters of acute vasoreactivity testing after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension

https://doi.org/10.26442/2075082X.2020.3.200418

Abstract

Aim. To study the effect of balloon pulmonary angioplasty (BPA) on the changes of pulmonary artery pressure, cardiac output and structural parameters of pulmonary arteries after acute vasoreactivity testing (AVT) in inoperable patients with chronic thromboembolic pulmonary hypertension (CTEPH). Materials and methods. The prospective study included 22 patients with inoperable CTEPH. 11 patients underwent intravascular ultrasound (IVUS) of the pulmonary arteries. The assessment of clinical and hemodynamic parameters, vasoreactivity, structural parameters of the pulmonary arteries according to IVUS data was performed at 2 visits - before the first BPA and after a series of BPA. Results. The patients underwent 2.3±1.4 stages of BPA. The follow up was 160 (85; 248) days. Positive changes after a series of BPA were revealed in clinical (functional class, distance in the 6-minute walk test, level of brain natriuretic peptide) and hemodynamic (systolic and mean pulmonary artery pressure, right atrium pressure, etc.) parameters. The results of the AVT after BPA demonstrated a decrease in the portion of “non-responders” from 63.6 to 55.5%, and a group of “responders” (16.7%) has appeared. According to IVUS before and after AVT, the response to iloprost administration was observed basically in branches of subsegmental pulmonary arteries and initially corresponded to the process of vasodilation. However, after a series of BPA there was noted a paradoxical reaction in the middle section after the AVT - a decrease in the vessel lumen and an increase in the thickness and area of the vessel wall. This effect is probably associated with the response to the test at the level of the microvasculature, as in pulmonary arterial hypertension before the onset of its pronounced structural changes. The data obtained confirm the reverse remodeling of the pulmonary vessels and the restoration of vasoreactivity after a series of BPA. Conclusion. BPA improves clinical and hemodynamic parameters, as well as pulmonary vasoreactivity, in inoperable patients with CTEPH. AVT may be included in the recommendations for the examination of patients with CTEPH to assess the effectiveness of BPA and determine the disease prognosis.

About the Authors

S. Y. Yarovoy
Myasnikov Institute of Cardiology of National Medical Research Center for Cardiology
Russian Federation


I. E. Chazova
Myasnikov Institute of Cardiology of National Medical Research Center for Cardiology
Russian Federation


Y. G. Matchin
Myasnikov Institute of Cardiology of National Medical Research Center for Cardiology
Russian Federation


N. M. Danilov
Myasnikov Institute of Cardiology of National Medical Research Center for Cardiology
Russian Federation


References

1. Чазова И.Е., Мартынюк Т.В. Клинические рекомендации по диагностике и лечению хронической тромбоэмболической легочной гипертензии (I часть). Терапевтический архив. 2016; 88 (9): 90-101.

2. Galiè N, Humbert M, Vachiery J et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart J 2015; 37 (1): 67-119.

3. Чазова И.Е., Мартынюк Т.В., Валиева З.С. и др. Евразийские клинические рекомендации по диагностике и лечению легочной гипертензии. Евразийский кардиол. журн. 2020; 1: 78-122.

4. Чазова И.Е., Мартынюк Т.В. Легочная гипертензия. М.: Практика, 2015; c. 81-102, 309-24, 563-604.

5. Lang I, Dorfmüller P, Noordegraaf A. The pathobiology of chronic thromboembolic pulmonary hypertension. Ann Am Thorac Soc 2016; 13 (Suppl. 3): S215-S221.

6. Albani S, Biondi F, Stolfo D et al. Chronic thromboembolic pulmonary hypertension (CTEPH). J Cardiovasc Med (Hagerstown). 2019; 20 (4): 159-68.

7. Sitbon O, Humbert M, Jaïs X et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005; 111 (23): 3105-11.

8. Xu Q, Yang Y, Geng J et al. Clinical study of acute vasoreactivity testing in patients with chronic thromboembolic pulmonary hypertension. Chin Med J (Engl) 2017; 130 (4): 382-91.

9. Thistlethwaite P, Mo M, Madani M et al. Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thorac Cardiovasc Surg 2002; 124 (6): 1203-11.

10. Pepke-Zaba J, Delcroix M, Lang I et al. Chronic thromboembolic pulmonary hypertension (CTEPH). Circulation 2011; 124 (18): 1973-81.

11. Madani M, Auger W, Pretorius V et al. Pulmonary endarterectomy: recent changes in a single institution’s experience of more than 2,700 patients. Ann Am Thorac Soc 2012; 94 (1): 97-103.

12. Данилов Н.М., Матчин Ю.Г., Чазова И.Е. Баллонная ангиопластика легочных артерий при неоперабельной хронической тромбоэмболической легочной гипертензии. Consilium Medicum. 2016; 18 (5): 59-61.

13. Сагайдак О.В., Данилов Н.М., Матчин Ю.Г. и др. Структурные изменения легочных артерий по данным внутрисосудистого ультразвука при проведении острой фармакологической пробы у больных с идиопатической легочной гипертензией. Кардиологический вестник. 2016; 11 (3): 60-4.

14. Yang Y, Yu Y, Yuan P et al. Sex differences of hemodynamics during acute vasoreactivity testing to predict the outcomes of chronic thromboembolic pulmonary hypertension. Clin Respir J 2020; 14 (7): 611-21.


Review

For citations:


Yarovoy S.Y., Chazova I.E., Matchin Y.G., Danilov N.M. Parameters of acute vasoreactivity testing after balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension. Systemic Hypertension. 2020;17(3):53-58. (In Russ.) https://doi.org/10.26442/2075082X.2020.3.200418

Views: 186


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2075-082X (Print)
ISSN 2542-2189 (Online)